drugset / Trial / NCT00293280

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00293280

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as lomustine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well lomustine works in treating patients with stage III or stage IV non-small cell lung cancer.

Timeline

Start
2005-07
Primary completion
2007-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lomustine Small molecule Oral

Indications